CYMABAY THERAPEUTICS INC (CBAY)
US23257D1037 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -105.37M | -106.00M | -90.00M | -50.99M | -102.81M | |||
| Depreciation Amortization | 681.00K | 710.00K | 690.00K | 630.00K | 570.00K | |||
| Change In Working Capital | 5.63M | -2.34M | 6.35M | -1.59M | -3.91M | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 26.53M | 23.55M | 13.53M | 7.22M | 8.23M | |||
| OPERATING CASH FLOW | -72.53M | -84.08M | -69.43M | -44.73M | -97.91M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -445.00K | -150.00K | -90.00K | -20.00K | -320.00K | |||
| Other Investing Activity | -86.12M | -45.84M | 48.68M | 47.98M | -34.03M | |||
| INVESTING CASH FLOW | -86.57M | -45.99M | 48.59M | 47.96M | -34.35M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 25.00M | 47.74M | N/A | 0.00 | |||
| Stock Issued/Repurchased | 10.63M | 10.00K | 70.72M | 90.00K | 390.00K | |||
| Other Financing Activity | 335.14M | -460.00K | N/A | 0.00 | 107.75M | |||
| FINANCING CASH FLOW | 345.77M | 24.55M | 118.46M | 90.00K | 108.13M | |||
| CHANGE IN CASH | 186.67M | -105.52M | 97.62M | 3.32M | -24.13M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -72.53M | -84.08M | -69.43M | -44.73M | -97.91M | |||
| Capital Expenditure | -445.00K | -150.00K | -90.00K | -20.00K | -320.00K | |||
| FREE CASH FLOW | -72.98M | -84.23M | -69.52M | -44.75M | -98.23M | |||
All data in USD